ArticleMedical oncology (Northwood, London, England)2024

Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer.

Zhuo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.